Company Filing History:
Years Active: 2021
Title: Gardiner Smith: Innovator in Cognitive Function Enhancement
Introduction
Gardiner Smith is an accomplished inventor based in Elizabeth, West Virginia. He has made significant contributions to the field of cognitive function improvement through his innovative inventions. His work focuses on addressing cognitive impairments associated with various central nervous system disorders.
Latest Patents
Gardiner Smith holds a patent for "Methods and compositions for improving cognitive function." This invention relates to compositions that include a synaptic vesicle glycoprotein 2A (SV2A) inhibitor in an extended release form, along with an acetylcholinesterase inhibitor (AChEIs). The patent outlines the use of these compositions in treating cognitive impairments linked to conditions such as age-related cognitive impairment, Mild Cognitive Impairment (MCI), dementia, Alzheimer's Disease (AD), and other mental health disorders.
Career Highlights
Gardiner Smith is associated with Agenebio, Inc., where he continues to develop and refine his innovative approaches to cognitive health. His work has the potential to impact the lives of individuals suffering from various cognitive disorders, providing new avenues for treatment and management.
Collaborations
(Section skipped due to space constraints.)
Conclusion
Gardiner Smith's contributions to cognitive function enhancement through his patented inventions highlight his role as a key innovator in the field. His work at Agenebio, Inc. continues to pave the way for advancements in treating cognitive impairments.